These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16842980)

  • 21. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for treating cognitive deficits in schizophrenia.
    Bowie CR; Jaga K
    Expert Rev Neurother; 2007 Mar; 7(3):281-7. PubMed ID: 17341176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECNP consensus meeting, March 5-6, 1999, Nice. Post traumatic stress disorder: guidelines for investigating efficacy of pharmacological intervention. ECNP and ECST.
    Montgomery S; Bech P
    Eur Neuropsychopharmacol; 2000 Jul; 10(4):297-303. PubMed ID: 10871713
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I; Cechnicki A; Kalisz A
    Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schizophrenia: measurements of psychopathology.
    Lindenmayer JP; Harvey PD; Khan A; Kirkpatrick B
    Psychiatr Clin North Am; 2007 Sep; 30(3):339-63. PubMed ID: 17720027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive deficits in patients with schizophrenia: effects and treatment.
    Keefe RS
    J Clin Psychiatry; 2007; 68 Suppl 14():8-13. PubMed ID: 18284272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How should DSM-V criteria for schizophrenia include cognitive impairment?
    Keefe RS; Fenton WS
    Schizophr Bull; 2007 Jul; 33(4):912-20. PubMed ID: 17567627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
    Kern RS; Nuechterlein KH; Green MF; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Mintz J; Seidman LJ; Stover E; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):214-20. PubMed ID: 18172018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attributional style, symptomatology and awareness of illness in schizophrenia.
    Fraguas D; Mena A; Franco C; Martín-Blas MM; Nugent K; Rodríguez-Solano JJ
    Psychiatry Res; 2008 Apr; 158(3):316-23. PubMed ID: 18258307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Depressive states in schizophrenia: etiology and management].
    Dardennes R
    Soins Psychiatr; 1993; (154-155):23-7. PubMed ID: 8122155
    [No Abstract]   [Full Text] [Related]  

  • 34. Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia.
    Moran PM; Owen L; Crookes AE; Al-Uzri MM; Reveley MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):116-23. PubMed ID: 17764799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echopraxia in schizophrenia: possible mechanisms.
    Pridmore S; Brüne M; Ahmadi J; Dale J
    Aust N Z J Psychiatry; 2008 Jul; 42(7):565-71. PubMed ID: 18612859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th.o.m.a.s.: an exploratory assessment of Theory of Mind in schizophrenic subjects.
    Bosco FM; Colle L; De Fazio S; Bono A; Ruberti S; Tirassa M
    Conscious Cogn; 2009 Mar; 18(1):306-19. PubMed ID: 18667334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic symptoms in early psychotic and depressive disorders.
    Schultze-Lutter F; Ruhrmann S; Picker H; von Reventlow HG; Brockhaus-Dumke A; Klosterkötter J
    Br J Psychiatry Suppl; 2007 Dec; 51():s31-7. PubMed ID: 18055935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Pogge DL; Insalaco B; Bertisch H; Bilginer L; Stokes J; Cornblatt BA; Harvey PD
    Psychiatry Res; 2008 Jul; 160(1):47-54. PubMed ID: 18534688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.